NDC 76961-101

Rolvedon

Eflapegrastim-xnst

Rolvedon is a Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Spectrum Pharmaceuticals, Inc.. The primary component is Eflapegrastim.

Product ID76961-101_e9602b05-7b39-2b6a-e053-2995a90a78ee
NDC76961-101
Product TypeHuman Prescription Drug
Proprietary NameRolvedon
Generic NameEflapegrastim-xnst
Dosage FormInjection, Solution
Route of AdministrationSUBCUTANEOUS
Marketing Start Date2022-09-26
Marketing CategoryBLA /
Application NumberBLA761148
Labeler NameSpectrum Pharmaceuticals, Inc.
Substance NameEFLAPEGRASTIM
Active Ingredient Strength13 mg/.6mL
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 76961-101-01

.6 mL in 1 SYRINGE, GLASS (76961-101-01)
Marketing Start Date2022-09-26
NDC Exclude FlagN
Sample Package?N

Drug Details


Trademark Results [Rolvedon]

Mark Image

Registration | Serial
Company
Trademark
Application Date
ROLVEDON
ROLVEDON
97211650 not registered Live/Pending
Spectrum Pharmaceuticals, Inc.
2022-01-10

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.